Skip to main content

Andrew Penn, RN, MS, NP, CNS, APRN-BC

Andrew Penn, RN, MS, NP, CNS, APRN-BC
March 27, 2020
BLOG: As a health care professional, I have watched the progress of the COVID-19 pandemic with alternating measures of horror, dread, fascination, frustration, and fear.
Andrew Penn, RN, MS, NP, CNS, APRN-BC
March 10, 2020
BLOG: I’ve been washing my hands a lot this week. Transiting through an airport, a task once done without thought, suddenly seems like tiptoeing through a minefield of COVID-19.
Andrew Penn, RN, MS, NP, CNS, APRN-BC
January 21, 2020
BLOG: Walmart is planning to use its vast network of stores to host mental health clinics where self-paying patients could pay $1 per minute to see a mental health clinician.
Andrew Penn, RN, MS, NP, CNS, APRN-BC
January 06, 2020
BLOG: When we sit with the pain of our patients, it’s important to remember that our psyches do not end at the edges of our skin, and that which is going on in the larger world impacts our inner…
Andrew Penn, RN, MS, NP, CNS, APRN-BC
December 18, 2019
BLOG: I sat down with Saundra Jain, MA, PsyD, LPC to better understand the connection between wellness and psychedelics.
Andrew Penn, RN, MS, NP, CNS, APRN-BC
November 18, 2019
BLOG: It is becoming increasingly clear that the practice of psychiatry will be changing from one in which we ask our patients to take a daily pill to one where we deliver procedures that have…
Andrew Penn, RN, MS, NP, CNS, APRN-BC
October 25, 2019
BLOG: Have you ever wished you could pick up the phone and call someone you’ve lost and leave them a message?
Andrew Penn, RN, MS, NP, CNS, APRN-BC
September 04, 2019
BLOG: Currently, many of our patients are using cannabinoids, especially cannabidiol (CBD) to treat their own symptoms—ranging from insomnia, to anxiety, to depression.
Andrew Penn, RN, MS, NP, CNS, APRN-BC
June 25, 2019
BLOG: I recently completed 24 hours of online training to qualify for a buprenorphine “X” waiver and can now, in addition to the schedule II to V drugs that I was already permitted to prescribe as a…
Andrew Penn, RN, MS, NP, CNS, APRN-BC
May 23, 2019
BLOG: Esketamine represents the first psychedelic treatment approved by the FDA for a psychiatric condition.
Back to Top